These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Treatment of Parkinson's syndrome with L-dopa and L-carbidopa (author's transl)].
    Author: Hanzal F.
    Journal: MMW Munch Med Wochenschr; 1976 May 14; 118(20):653-6. PubMed ID: 818540.
    Abstract:
    In a clinical investigation on the treatment of Parkinson's syndrome it is shown that a combination of L-dopa with decarboxylase inhibitor (L-carbidopa) shows advantages compared to treatment with L-dopa alone. To achieve the same therapeutic effect a quarter of the dose is sufficient; the good tolerance, even in relation to the digestive and cardiovascular apparatus, permits the use of relatively larger daily doses. The favorable action appears more quickly. The effect of the treatment can be potentiated by pyridoxine. The only disadvantage is the fairly frequent occurrence of hyperkinesia, especially of oral automatism. But treatment does not need to be broken off because of this.
    [Abstract] [Full Text] [Related] [New Search]